Legend Biotech Corporation (LEGN)
NASDAQ: LEGN · Real-Time Price · USD
18.73
-0.59 (-3.05%)
Oct 2, 2026, 2:03 PM EDT - Market open
Legend Biotech Stock Forecast
Stock Price Forecast
According to 13 analysts polled by S&P Global, Legend Biotech stock has a consensus rating of "Buy" and an average price target of $46.9. The average 1-year stock price forecast is 150.40% higher than the current stock price, while the lowest is $24 (+28.14%) and the highest is $74 (+295.09%).
Price Target: $46.9 (+150.40%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Legend Biotech stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 9 | 8 | 7 | 6 | 5 | 4 |
| Buy | 5 | 5 | 5 | 5 | 5 | 5 |
| Hold | 2 | 2 | 2 | 4 | 5 | 5 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 16 | 15 | 14 | 15 | 15 | 14 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Hold Reiterates $28 → $24 | Hold | Reiterates | $28 → $24 | +28.14% | Oct 2, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $65 | Buy | Reiterates | $65 | +247.04% | Sep 28, 2026 |
| Barclays | Barclays | Buy Maintains $78 → $74 | Buy | Maintains | $78 → $74 | +295.09% | Sep 11, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $58 | Buy | Maintains | $58 | +209.66% | Sep 9, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $49 → $48 | Buy | Maintains | $49 → $48 | +156.27% | Aug 12, 2026 |
Financial Forecast
Revenue This Year
1.43B
from 1.03B
Increased by 39.04%
Revenue Next Year
1.79B
from 1.43B
Increased by 25.29%
EPS This Year
-0.01
from -1.60
EPS Next Year
1.05
from -0.01
EPS and Forward PE are based on non-GAAP adjusted numbers.